BreakBio will be working on behalf of patients with metastatic colorectal cancer to achieve a breakthrough. We are a dedicated team of world renowned specialists with a cross section of expertise in immunology, immunotherapy, vaccines, bioinformatic analyses, cloud software platforms and big data. We bridge super specialties that have historically been compartmentalized and adopt a simultaneous multi-modal approach to curing colorectal cancer, the cancer that kills the 2nd highest number of people in the US.
Our intense effort started when one of our relatives was diagnosed with colon cancer. Many great scientists across the world are working on this cancer. We at BreakBio, respect them and admire their great work.
BreakBio is planning a treatment that has curative intent: instead of prolonging life, we want to cure some patients. We have designed a sophisticated, simultaneous multi-pronged attack on cancer cells. It is personalized per patient and includes an immunotherapy component.
We will be doing a Phase I clinical trial. Please wish patients who choose to enroll the very best. We thank you for your support.
Roy de Souza and the BreakBio Team
Reaching for Breakthrough